Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | F2 | P00734 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590460 | 0.93 | F2 (0.56) | SLC6A2F2OPRM1OPRD1OPRK1 | |
| SCHEMBL29630540 | 0.93 | SLC6A2 (0.58) | SLC6A2OPRM1OPRD1 | |
| SCHEMBL29878521 | 0.90 | OPRM1 (0.56) | SLC6A2F2OPRM1OPRD1OPRK1 | |
| SCHEMBL31462032 | 0.90 | OPRM1 (0.61) | F2OPRM1OPRD1OPRK1POLB | |
| SCHEMBL29679668 | 0.89 | SLC6A2 (0.61) | SLC6A2F2OPRM1OPRD1OPRK1 | |
| SCHEMBL29456373 | 0.88 | OPRM1 (0.64) | SLC6A2F2OPRM1OPRD1OPRK1 | |
| SCHEMBL29579280 | 0.87 | F2 (0.56) | SLC6A2F2OPRM1OPRD1OPRK1 | |
| SCHEMBL31316619 | 0.87 | F2 (0.53) | SLC6A2F2OPRM1OPRD1OPRK1 | |
| SCHEMBL30005604 | 0.87 | F2 (0.59) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL29664244 | 0.87 | OPRM1 (0.57) | F2OPRM1OPRD1OPRK1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |